527 filings
8-K
TENX
Tenax Therapeutics Inc
18 Nov 20
Regulation FD Disclosure
4:17pm
10-Q
2020 Q3
TENX
Tenax Therapeutics Inc
Quarterly report
16 Nov 20
4:16pm
8-K
TENX
Tenax Therapeutics Inc
15 Oct 20
Tenax Therapeutics Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation
8:46am
424B3
TENX
Tenax Therapeutics Inc
1 Oct 20
Prospectus supplement
9:13am
EFFECT
TENX
Tenax Therapeutics Inc
1 Oct 20
Notice of effectiveness
12:15am
CORRESP
fk1vjfe8gcdgosm4
29 Sep 20
Correspondence with SEC
12:00am
CORRESP
pjd8o0yd1g z39nw
11 Sep 20
Correspondence with SEC
12:00am
4
ldvsg0wg2di6cl1khcm4
9 Sep 20
TENAX THERAPEUTICS / Steven Boyd ownership change
7:04pm
UPLOAD
zne17y4fth9ookip rsn
4 Sep 20
Letter from SEC
12:00am
4
v4xfz3q19bcoqdh8
3 Sep 20
TENAX THERAPEUTICS / Steven Boyd ownership change
5:39pm
4
cr5gx8t 485h8
31 Aug 20
TENAX THERAPEUTICS / Steven Boyd ownership change
7:38pm
4
aqk6lb3o5bhfv9mx9i
26 Aug 20
TENAX THERAPEUTICS / Steven Boyd ownership change
5:47pm
4
c8fb fhe1w8hkfu
21 Aug 20
TENAX THERAPEUTICS / Steven Boyd ownership change
5:56pm
SC 13G/A
wh8 77cf6o2er6y
7 Aug 20
TENAX THERAPEUTICS / BlackRock ownership change
12:00am
D
w69i1viu0b09jk3
22 Jul 20
$5.17M in options / securities to be acquired, sold $5.17M, 1 investor
5:00pm
3
dnmvf1l0x8jxx5ayj5rr
21 Jul 20
TENAX THERAPEUTICS / Illya Keith Maher ownership change
4:40pm
8-K
1n9j7rnno31ngwoevs
20 Jul 20
Tenax Therapeutics Expands Board of Directors with the Appointment
9:00am